Results

Total Results: 2,901 records

Showing results for "medication".
Users also searched for: medication reconciliation

81. Standardized Library of Asthma Outcome Measures (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/white-paper-library-asthma.pdf
    April 01, 2019 - Of note, several outcome measures focus on change over time, such as change in medication dosage or … Clinical Response Change in asthma controller medication use Measured by patient/caregiver self-report … An additional quick-relief medication includes ipratropium bromide. … Events of Interest Medication adverse events Adverse events related to asthma medications. … medication dispensed during the measurement year divided by the number of canisters of total asthma

82. Evaluation of Effectiveness and Safety of Antiepileptic Medications in Patients With Epilepsy (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_research-protocol.pdf
    February 01, 2008 - (medication classes, individual medications and medications meeting the definition of having a narrow … (individual drug names, medication formulation, dose, schedule, bioequivalence status (if applicable … will be compared with an individual older epileptic medication. … In the “A” rated generic medication versus another “A” rated generic medication evaluation, only “A” … Assessment: generic substitution for antiepileptic medication. Neurology 1990;40:1641-3. 31.

83. Making Healthcare Safer IV: Summary of Findings, 2023-2024 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-1-year-final-report-updated-title_0.pdf
    May 01, 2024 - o Improved medication-related CDSS were associated with reductions of medication errors and adverse … Deprescribing To Reduce Medication Harms in Older Adults 11a. … • Conclusion o Deprescribing reduces medication counts, inappropriate medication use, and pharmacy … involving CDSS to reduce medication errors and adverse drug events. … Deprescribing To Reduce Medication Harms in Older Adults 11a.

84. A Rapid Evidence Review of Retention Strategies for Medications for Addiction Treatment (MAT) in Adults with Opioid Use Disorder | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/retention-strategies-opioid-use-disorder/rapid-protocol
    May 08, 2019 - impacts the retention of patients receiving MAT, such as: Pharmacologic aspects (e.g., choice of medication … , formulation [extended release], dosage of medication, duration) Psychosocial adjuncts (e.g. counseling … MAT medication/program reimbursement) Social services/logistic support (e.g., housing, transportation … Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis … Retention in medication-assisted treatment for opiate dependence: A systematic review .

85. Crosscutting-Horizon-Scan-High-Impact-1312 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1312.pdf
    December 01, 2013 - When the patient ingests the medication with embedded sensor, digestive fluids activate the sensor … Lack of patient adherence to the medication regimens being tested in clinical trials was cited in a … But some experts were skeptical about this technology’s potential to improve medication adherence … When the patient swallows the sensor-embedded pill, the medication releases the chip, which is then … Medication adherence was >85%.

86. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children_executive.pdf
    February 01, 2012 - In general, the choice of medication in children and adolescents is often driven by side-effect profiles … Do FGAs and SGAs differ in medication-associated adverse events when used in children, youth, and young … • Medication adherence and persistence. • School performance and attendance. … Schizophrenia Medication adherence FGA vs. SGA (2 RCT, 1 PCS) Low No significant difference. … A three-country comparison of psychotropic medication prevalence in youth.

87. Crosscutting-Horizon-Scan-High-Impact-1406 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1406.pdf
    June 01, 2014 - The patient ingests the medication along with the sensor, and digestive fluids activate the sensor … Lack of patient adherence to the medication regimens tested in clinical trials has been implicated … Thus, whether this would add to overall costs or offset costs of nonadherence to medication regimens … among experts about this technology’s potential to improve medication adherence and health outcomes … Medication adherence was >85%.

88. 15 Crosscutting Potential High Impact June 2012 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/15_crosscutting_potential_high_impact_june_2012.pdf
    January 01, 2012 - Overall High Impact Potential: Intelligent pills to monitor patient medication use .............. 6 … *Intelligent pills (Raisin System ) to monitor patient medication adherence Moderately high 4. …  Potential for High Impact: High Intelligent Pills to Monitor Patient Medication Adherence … Medication adherence was >85%. … on the way the medication is prescribed, not necessarily on the way it is actually taken.

89. Epilepsy-Medicine Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_surveillance.pdf
    August 01, 2012 - These studies compared the use of long tolerated innovator antiepileptic medication with short-term … As such, the switchback from a generic to an innovator antiepileptic medication may or may not be due … New Evidence: Switching from an innovator to a generic antiepileptic medication … These studies compared the use of long tolerated innovator antiepileptic medication with short-term … New Evidence: While data on BCS class for the innovator versus generic antiepileptic medication

90. Epilepsy-Medicine Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_surveillance.pdf
    August 01, 2012 - These studies compared the use of long tolerated innovator antiepileptic medication with short-term … As such, the switchback from a generic to an innovator antiepileptic medication may or may not be due … New Evidence: Switching from an innovator to a generic antiepileptic medication … These studies compared the use of long tolerated innovator antiepileptic medication with short-term … New Evidence: While data on BCS class for the innovator versus generic antiepileptic medication

91. Management of Suicidal Thoughts in Youth (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/suicidal-thoughts-young-people-key-question_0.pdf
    January 01, 2019 - ages 10- 24y with suicidal thoughts or behaviors Intermediate/process outcomes • Adherence to medication … • Participation in treatment Harms: medication side effects, stigma Interventions (e.g. … Any harms: medication side effects, stigma Timing All/any (short term, long term) Figure 1.

92. Crosscutting Hi Impact (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/crosscutting_hi_impact.pdf
    January 01, 2012 - Overall High Impact Potential: Intelligent pills to monitor patient medication use .............. 3 … *Intelligent pills to monitor patient medication use 3. … Medication adherence was >85%. … As one commentator who is a pharmacist stated, “Clinicians might alter or change a medication based … on the way the medication is prescribed, not necessarily on the way it is actually taken.

93. S66 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/s66.pdf
    October 01, 2007 - In this situation, the new episode of use started on the date the new medication was filled. … MPR indicates medication possession ratio. … Adherence to medication. N Engl J Med. 2005;353:487–497. 19. … The language of medication-taking. Ann Intern Med. 2000;132:926–930. 21. … Evaluating medication effects outside of clinical trials: new- user designs.

94. Alcohol-Misuse-Drug-Therapy Clinician (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_clinician.pdf
    February 01, 2016 - Head-to-head trials have not consistently established the superiority of one medication over another … Factors that may guide medication choices include frequency of administration, dosing schedule or other … Medication Outcome N Studiesa N Subjects Finding Effect Size (95% CI) NNTb SOE Acamprosate vs. placebo … b This medication has not been approved by the FDA for the treatment of alcohol dependence, alcohol … In most studies, patients abstained for at least 3 days before starting medication.

95. Politi (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/politi.pdf
    December 26, 2012 - Decisions: • BCS vs. mastectomy for average risk patients with early stage breast cancer • Diabetes medication … • Stochastic Uncertainty • Frequencies (or percentages) Pictographs Example: MD discussing BP  medication … About 2 out of 100 patients who take this medication will develop low blood pressure. … What not to do: 2 out of 10 patients who  take this medication  could  develop low blood  pressure

96. Crosscutting-Horizon-Scan-High-Impact-1512 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1512.pdf
    December 01, 2015 - The patient ingests the medication along with the sensor, and digestive fluids activate the sensor … Lack of patient adherence to medication regimens tested in clinical trials has been implicated as a … Whether this will add to overall costs or offset costs of nonadherence to medication regimens is not … or into the active medication itself.2,4,5 The technology’s manufacturer states that the sensor is … Medication adherence was >85%.

97. Crosscutting-Horizon-Scan-High-Impact-1506 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - The patient ingests the medication along with the sensor, and digestive fluids activate the sensor … Lack of patient adherence to medication regimens tested in clinical trials has been implicated as a … Thus, whether this will add to overall costs or offset costs of nonadherence to medication regimens … Medication adherence was >85%. … Proteus promotes medication adherence using ingestible sensors. Gray Sheet. 2012 Aug 6. 20.

98. Acute Treatment for Episodic Migraine: Surveillance Report 2 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-2.pdf
    June 01, 2022 - ; (4) dose of medication; (5) duration of treatment? … ; (4) dose of medication; (5) the duration of therapy? … *" or "neuromuscular drug*" or "neuromuscular medication*" or "neuromuscular nondepolarizing agent*" … *" or "neuromuscular drug*" or "neuromuscular medication*" or "neuromuscular nondepolarizing agent*" … Acute migraine medication and medication overuse headache: a systematic literature review.

99. 15 Crosscutting Potential High Impact 2012-12-11 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/15_crosscutting_potential_high_impact_2012-12-11.pdf
    January 01, 2012 - Overall high-impact potential: intelligent pills (The Raisin System) to monitor patient medication … (wound care, medication reconciliation), prevention (immunizations, fall assessment), and referral … Medication adherence was >85%. … HS262 - Intelligent pills (Raisin System) to monitor patient medication use in chronic diseases. … HS262 - Intelligent pills (Raisin System) to monitor patient medication use in chronic diseases.

100. Acute Treatment for Episodic Migraine: Surveillance Report 2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/episodic-migraine-surveillance-report-2.pdf
     June 01, 2022 - ; (4) dose of medication; (5) duration of treatment? … ; (4) dose of medication; (5) the duration of therapy? … *" or "neuromuscular drug*" or "neuromuscular medication*" or "neuromuscular nondepolarizing agent*" … *" or "neuromuscular drug*" or "neuromuscular medication*" or "neuromuscular nondepolarizing agent*" … Acute migraine medication and medication overuse headache: a systematic literature review.